Research Center Shares Test-bed with Industrial Partners

Achievement date: 
2014
Outcome/accomplishment: 

The Center for Structured Organic Particulate Systems (C-SOPS), an NSF-funded Engineering Research Center (ERC) based at Rutgers University, recently hosted an open house for industrial partners at partner institution the New Jersey Institute of Technology (NJIT) to commercialize the technology developed at their research facility. On September 24, 2013, the facility, called Test-bed 2, opened its doors to 40 people from 17 companies.

Impact/benefits: 

This event marks an important step for this and other ERCs. The technologies from Test-bed 2 available for commercialization were received very well by those in attendance and even led to the signing of an agreement with Tapemark, a major flexible rolled goods manufacturer based in Minnesota, to collaborate on further advancing some of these technologies. The team is optimistic about the response they received and expect to form more collaborations with other companies

Explanation/Background: 

At Test-bed 2, C-SOPS conducts research on thin-film drug delivery systems. Their work focuses on controlling the release of drugs by precisely incorporating active pharmaceutical ingredients (APIs) into films that are as thin as a hair.

The companies represented by those in attendance include some of the largest manufacturers of pharmaceuticals and films. Tapemark was joined by Actavis, Amneal, Aptapharma, BMS, DermPathe, FMC, GlaxoSmithKline, iCeutica, Johnson & Johnson, Kashiv Pharma, LTS Corp, Merck & Co., MonoSol Rx, Novel Labs, PAC Pharma, and Princeton Biopharma at the open house. Adhesives Research and Teva visited Test-bed 2 at later dates.